Skip to main content
. 2000 Jun 17;320(7250):1642–1646. doi: 10.1136/bmj.320.7250.1642

Table 1.

Number of cases and controls for each cancer site by sex and prescription of non-steroidal anti-inflammatory drug (NSAID) in 13-36 months before diagnosis of case

Cancer site No of cases No of controls No prescribed NSAID in 13-36 months before diagnosis of case
Cases Controls
Bladder:
 Male    764   2291  200  532
 Female    277    831  100  239
 Total   1041   3122  300  771
Breast:
 Male     21     63    8   14
 Female   3084   9209  902 2684
 Total   3105   9272  910 2698
Colon:
 Male    668   1997  181  512
 Female    700   2092  197  638
 Total   1368   4089  378 1150
Lung:
 Male   1653   4925  386 1204
 Female    907   2718  271  808
 Total   2560   7643  657 2012
Oesophagus:
 Male    348   1044   86  286
 Female    202    606   50  165
 Total    550   1650  136  451
Pancreas:
 Male    248    742   58  161
 Female    265    793   88  235
 Total    513   1535  146  396
Prostate:
 Male   1813   5354  570 1350
Rectum:
 Male    343   1028   79  255
 Female    250    750   73  227
 Total    593   1778  152  482
Stomach:
 Male    389   1165   92  302
 Female    224    672   56  170
 Total    613   1837  148  472
All sites:
 Male   6258 17 593 1660 4326
 Female   5916 17 341 1739 5067
 Total  12 174*  34 934 3399 9393
*

Eighteen cases (11 men, seven women) had multiple site cancer and were excluded from individual site categories. Figure is less than total number of controls for each site individually as some patients were by chance selected as controls for more than one patient